Behavioral Activation + Occupational Therapy: An Innovative Intervention for Empowered Sel
Approximately 45% of older adults in the U.S. have 2 or more chronic health conditions (e.g., arthritis, hypertension, diabetes) in addition to functional limitations that prevent performance of health self-management activities. Self-management continues to be the gold standard for managing MCC, but functional limitat
| Condition(s) | Multiple Chronic Conditions, Disability Physical |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Approximately 45% of older adults in the U.S. have 2 or more chronic health conditions (e.g., arthritis, hypertension, diabetes) in addition to functional limitations that prevent performance of health self-management activities. Self-management continues to be the gold standard for managing MCC, but functional limitations create difficulty with these activities (e.g., physical activity, symptom monitoring). Restricted self-management accelerates the downward spiral of disability and accumulating chronic conditions which, in turn, increases rates of institutionalization and death by 5-fold. Currently, there are no tested interventions designed to improve independence in health self-management activities in older adults with MCC and functional limitations. Research suggests that older adult |
| Who can participate | Inclusion Criteria: * at least 2 chronic conditions * at least 1 functional limitation * intention to set at least 1 physical activity goal * live within 15 miles of University of Oklahoma (OU) Schusterman Center Exclusion Criteria: * life expectancy less than 6 months * progressive neurological condition * in active treatment for cancer * not English speaking * cognitive impairment * current or history of severe mental illness * in concurrent treatment with occupational and physical therapy |
| Ages | 60 Years |
| Sex | All |
| Lead sponsor | University of Oklahoma |
| Locations | Tulsa, Oklahoma, United States |
| Start date | 2022-11-01 |
| NCT ID | NCT05600465 |
| Official listing | https://clinicaltrials.gov/study/NCT05600465 |